Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
12
×
startups
12
×
boston top stories
new york blog main
san francisco blog main
biotech
new york top stories
boston
deals
san francisco top stories
vc
clinical trials
cancer
sanofi
venture capital
alnylam pharmaceuticals
biogen
fda
gene therapy
ipo
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
third rock ventures
boulder/denver blog main
boulder/denver top stories
crispr
deerfield management
detroit blog main
detroit top stories
drug discovery
europe blog main
europe top stories
general atlantic
gilead sciences
What
medicines
12
×
new
therapeutics
years
bio
drugs
adds
ago
aiming
aims
announced
biotech
ceo
covid
deal
developing
disease
diseases
drug
field
gene
ipo
launch
pipeline
research
roundup
startup
acquisitions
activity
adding
address
aim
alliance
allosteric
ambys
approach
approvals
areas
aren’t
backed
Language
unset
Current search:
startups
×
medicines
×
" national top stories "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”